Advances on circulating fetal DNA in maternal plasma

Chinese Medical Journal

Volumn 120, Issue 14, 2007, Pages 1256-1259

  Fu, Xian Hu ^a   Chen, Han Ping ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Fetal DNA; Noninvasive prenatal diagnosis

Indexed keywords

DNA; MASPIN;

ANALYTIC METHOD; ARTICLE; DNA DETERMINATION; DNA SEQUENCE; EPIGENETICS; FIRST TRIMESTER PREGNANCY; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; GENOTYPE; HERITABILITY; HUMAN; MATERNAL PLASMA; NON INVASIVE MEASUREMENT; POLYMERASE CHAIN REACTION; PRENATAL DIAGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECOND TRIMESTER PREGNANCY; SENSITIVITY AND SPECIFICITY; SEX DETERMINATION; SINGLE NUCLEOTIDE POLYMORPHISM; SRY GENE; THIRD TRIMESTER PREGNANCY; Y CHROMOSOME;

EID: 34547768203     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200707020-00010     Document Type: Article

References (50)

1. Lo YMD, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW, et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997; 350: 485-487.
2. Birch L, English CA, Donoghue K, Barigye O, Fisk NM, Keer JT, et al. Accurate and robust quantification of circulating fetal and total DNA in maternal plasma from 5 to 41 weeks of gestation. Clin Chem 2005; 51: 312-320.
3. Zimmermann B, El-Sheikhah A, Nicolaides Y, Holzgreve W, Hahn S. Optimized real-time quantitative PCR measurement of male fetal DNA in maternal plasma. Clin Chem 2005; 51: 1598-1604.
4. Costa JM, Benachi A, Gautier E. New strategy for prenatal diagnosis of X-linked disorders. N Engl J Med 2002; 346: 1502.
5. Clausen FB, Krog GR, Rieneck Y, Lundqukst R, Finning K, Dickmeiss E, et al. Antenatal determination of fetal RhD-blood type based on fetal DNA in plasma from the RhD-negative mother. Ugeskr Laegar 2006; 168: 2568-2570.
6. Brojer E, Zupanska B, Guz K, Orzinska A, Kalinska A. Noninvasive determination of fetal RhD status by examination of cell-free DNA in maternal plasma. Transfusion 2005; 45: 1473-1480.
7. Van der schoot CE, Soussan AA, koalevijn AA. Noninvasive antenatal RhD typing. Trarsfus Clin Biol 2006; 13: 53-57.
8. Chiu RWK, Lau TY, Leung TN, Chow KCK, Chui DHK, Lo YMD. Prenatal exclusion of beta-thalassaemia major by examination of maternal plasma. Lancet 2002; 360: 998-1000.
9. Li Y, Di Naro E, Vitucci A, Zimmermann B, Holzgreve W, Hahn S. Detection of paternally inherited fetal point mutations for beta-thalassemia using size-fractionated cell-ftee DNA in maternal plasma. JAMA 2005; 293: 843-849.
10. Chiu RWY, Lau TK, Cheung PT, Gong ZQ, Leung TN, Lo YMD. Noninvasive prenatal exclusion of congenital adrenal hyperplasia by maternal plasma analysis: a feasibility study. Clin Chem 2002; 48: 778-780.
11. Saito H, Sekizawa. A, Morimoto T, Suzuki M, Yanaihara T. Prenatal DNA diagnosis of a single-gene disorder from maternal plasma. Lancet 2000; 356: 1170.
12. Cotter AM, Martin CM, O'leary JJ, Daly SF. Increased fetal DNA in the maternal circulation in early pregnancy is associated with an increased risk of preeclampsia. Am J Obstet Gynecol 2004; 191: 515-520.
13. Zhong XY, Gebhardt S, Hiclermann R, Tofa KC, Holzgreve W, Hahn S. Parallel assessment of circulatory fetal DNA and corticotrophin-releasing hormone mRNA in early- and late-onset preeclampsia. Clin Chem 2005; 51: 1730-1733.
14. Zhong XY, Holzgreve W, Gebhardt S, Hillermann R, Tofa KC, Gupta AY, et al. Minimal alteration in the ratio of circulatory fetal DNA to fetal corticotrophin-releasing hormone mRNA level in preeclampsia. Fetal Diagn Ther 2006; 21: 246-249.
15. Leung TN, Zhang J, Lau TK, Hjelm NM, Lo YMD. Maternal plasma fetal DNA as a marker for preterm. Lancet 1998; 352: 1904-1905.
16. Shimada K, Murakami K, Shozu M, Segawa T, Sumitani H, Inoue M. Sex-determining region Y levels in maternal plasma: evaluation in abnormal pregnancy. J Obstet Gynaecol Res 2004; 30: 148-154.
17. Tong YK, Lo YM. Diagnostic developments involving cell-free (circulating) nucleic acids. Clin Chim Acta 2006; 363: 187-196.
18. Stenman J, Orpana A. Accuracy in amplification. Nat Bioteclmol 2001; 19: 1011-1012.
19. Lo YMD, Poon L. The in and out of fetal DNA in maternal plasma. Lancet 2003; 361: 195-194.
20. Costa JM, Ernauct P. Automated assay for fetal DNA analysis in maternal serum. Clin Chem 2002; 48: 679-680.
21. Dhallan R, Au WC, Mattagajasingh S, Emche S, Bayliss P, Damewood K et al. Methods to increase the percentage of free fetal DNA recovered from the maternal circulation. JAMA 2004; 291: 1114-1119.
22. Zhong XY, Holzgreve W, Hahn S. Detection of fetal Rhesus D and sex using fetal DNA from maternal plasma by multiplex polymerase chain reaction. BJOG 2000; 107: 766-769.
23. Van der Schoot CE, Rijnders RJP, Bossers B, Haas M, Christiaens LGCM, Dee R. Real time PCR of bi-allelic insertion/deletion polymorphisms can serve as a reliable positive control for cell-free fetal DNA in non-invasive prenatal genotyping. Blood 2063; 102: 93.
24. Lo YMD, Zhang J, Leung TN, Lau Tk, Chang AM, Hjelm NM. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998; 62: 768-775.
25. Chan KC, Zhang J, Hui AB, Wong N, Lau TY, Leung TN, et al. Size distributions of maternal and fetal DNA in maternal plasma. Clin Chem 2004; 50: 88-92.
26. Li Y, Limmerman B, Rusterholz C, Kang A, Holzgreve W, Hahn S. Size separation of circulatory DNA in maternal of plasma permits ready detection of fetal DNA polymorphisms. Clin Chem 2004; 50: 1002-1011.
27. Li Y, Hdzgreve W, Page-Christianes GC, Gille JJ, Hahn S. Improved pr6natal detection of fetal point mutation for achondroplasia by the use of size-fractionated. Circulatory DNA in maternal plasma - a case report. Prenat Diagn 2004; 24: 896-898.
28. Rijnder RJ, Van Der luijt B, Peters ED, Goeree JK, Van Der Schoot CE, Ploos Van Amstel JK, et al. Earliest gestational age for fetal sexing in cell-free maternal plasma. Prenat Diagn 2003; 23: 1042-1044.
29. Stanghellini I, Bertorelli R, Capone L, Mazza V, Neri C, Percesepe A. Quantitation of DNA in maternal serum during the first trimester of pregnancy by the use of a DAZ repetitive probe. Mol Hum Reprod 2006; 12: 587-591.
30. Deng Z, Li Q, Li D, Wang D, Gao S, Wu G. The genetic polymorphisms of nine Y-STR loci with short fragment size alleles in southern Chinese Han population and its application in forensic science. Chin J Genet (Chin) 2006; 23: 470-474.
31. Deng Z, Wu G, Li Q, Zhang X, Liang Y, Li D, et al. Nonivasive genotyping of 9 Y-chromosame specific STR loci using circulating fetal DNA in maternal plasma by multiplex PCR. Prenat Diagn 2006; 26: 362-368.
32. Ge Q, Bai Y, Liu Z, Liu Q, Yan L, LU Z. Detection of fetal DNA in maternal plasma by microarry coupled with emulsion PCR. Clin Chim Acta 2006; 369: 82-88.
33. Poon LLM, Leung TN, Lau TK, Chow KC, Lo YMD. Differential DNA methylation between fetus and mother as a strategy for detecting fetal DNA in maternal plasma. Clin Chem 2002; 48: 35-41.
34. Jiang YH, Bressler J, Beaudet AL. Epigenetics and human disease. Annu Rev Genomics Hum Genet 2004; 5: 479-510.
35. Chim SSC, Tong YK, Chiu RWY, Lau Tk, Leung TN, Chan LYS, et al. Detection of the placental epigenetic signature of the maspin gene in maternal plasma. Proc Natl Acad Sci USA 2005; 102: 14753-14758.
36. Dokras A, Garder LM, Kirschmann DA, Seftor EA, Hendrix MJ. The tumor suppressor gene maspin is differentially regulated in cytotrophoblasts during human placenta development. Placenta 2002; 23: 274-280.
37. Futscher BW, Oshiro MM, Wozniak RJ, Holtan N, Hanigan CL, Duan H, et al. Role for DNA methylation in the control of cell type specific maspin expression. Nat Genet 2002; 31: 123-124.
38. Lui YY, Chik KW, Chiu RW, Ho CY, Lam CW, Lo YMD. Predominant hematopoietic origin of cell-free DNA in plasma and serum after sex-mismatched bone marrow transplantation. Clin Chem 2002; 48: 421-427.
39. Bianchi DW. Circulating fetal DNA: its origin and diagnostic potential - a review. Placenta 2004; 25: S93-S101.
40. Flori E, Doray B, Gautier E, Kohler M, Ernault P, Flori J, et al. Circulating cell-free fetal DNA in maternal serum appears to originate from cyto- and syncytio-trophoblastic cells - Case Report. Hum Reprod 2004; 19: 723-724.
41. Ng EKO, Tsui NBY, Lau TK, Leung TN, Chiu RWK, Panesar NS, et al. mRNA of placental origin is readily detectable in maternal plasma. Proc Natl Acad Sci USA 2003; 100: 4748-4753.
42. Herman JG, Graff JR, Myohanen S, Nelkion BD, Baylin SB. Methylation-spocific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996; 93: 9821-9826.
43. Jones M, Martienssen R. A blueprint for a Human Epigenome Project: the AACR Human Epigenome Workshop. Cancer Res 2005; 65: 11241-11246.
44. Yang I, Park IY, Jang SM, Shi LH, Ku HK, Park SR. Rapid quantification of DNA Methylation through dNMP analysis following bisulfite-PCR. Nucleic Acids Research 2006; 34: e78.
45. Ogino S, Kawasaki T, Brahmandam M, Cantor M, Kirkner GJ, Spiegelman D, et al. Precision and performance characteristics of bisulfite conversion and real-time PCR (Methylight) for quantitative DNA methylation analysis. JMD 2006; 8: 209-217.
46. Ehrich M, Nelson MR, Stanssens P, Zabeau K Liloglou T, Xinarianos G. Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry. Proc Natl Acad Sci USA 2005; 102: 15785-15790.
47. Schatz P, Dietrich D, Schuster M. Rapid analysis of CpG methylation patterns using RNase T1 cleavage and MALDI-TOF. Nucleic Acid Res 2004; 32: 167.
48. Song L, James SR, Kazim L, Karpf AR. Specific method for the determination of genomic DNA methylation by liquid chromatography-electrospray ionization tandem mass spectrometry. Anal Chem 2005; 77: 504-510.
49. Kaiser J. An early look at babies' genes. Science 2005; 309: 1476-1478.
50. Lo YM. Recent developments in fetal nucleic acids in maternal plasma: implications to noninvasive prenatal blood group genotyping. Transfus Clin Biol 2006; 13: 50-52.